Published 16 October 2008, doi:10.1136/bmj.a1902
Cite this as: BMJ 2008;337:a1902

Practice

Evidence Based Case Report

Aspirin in type 2 diabetes: is there any evidence base?

¹ University of Queensland, Royal Brisbane Hospital, Herston, Qld 4029, Australia , ² Discipline of General Practice, University of Queensland, Royal Brisbane Hospital

Aspirin is routinely given to patients with type 2 diabetes to prevent cardiovascular events, but does this practice have any evidence base?

The first 150 words of the full text of this article appear below.

While I (MW) was observing general practitioner consultations as a medical student, a 46 year old woman with type 2 diabetes presented for prescriptions. Because this is a common presentation, I thought this was one consultation that I should tune into. The patient’s diabetes was well controlled by diet and lifestyle alone. Her most recent glycated haemoglobin value was 6.1%. Hypercholesterolaemia (total cholesterol/high density lipoprotein cholesterol 4.2) and hypertension (blood pressure 125/80 mm Hg) were effectively managed with drugs. She was a regular smoker, which gave her an absolute cardiovascular risk of 5-10% (New Zealand cardiovascular risk calculator; www.nzgg.org.nz/guidelines/0035/CVD_Risk_Chart.pdf) over five years. However, one of the drugs she was taking didn’t make sense to me, so I asked my supervisor why someone with well controlled diabetes who was otherwise healthy should be on aspirin. "It’s routine to give someone with type 2 diabetes aspirin," he assured me. I must . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Antithrombotic Trialists' Collaboration
BMJ 2002 324: 71-86. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

there is even more recent evidence of inefficacy of aspirin for primary prevention

oscar,m jolobe
bmj.com, 14 Nov 2008 [Full text]

Calculation of cardiovascular risk

Paul Heath
bmj.com, 18 Nov 2008 [Full text]

Online poll

Find out more here>> and here>>